Mobile : +918451008897 (Timing : 10:00 am – 7:00 pm)
E-mail:info@shubhampharma.com
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
| Home | » Products | » Anti Cancer Drug | » Bleomycin-Bleocip |
BLEOMYCIN :
BLEOCIP contains Drug / Molecule Bleomycin
USAGE & DESCRIPTION :
BLEOCIP has used for Palliative treatment of Hodgkin disease and non-Hodgkin lymphoma; testicular carcinoma (eg, embryonal cell, choriocarcinoma, teratocarcinoma); sclerosis of malignant pleural effusions; squamous cell carcinomas (e.g., head, neck, cervix, vulva).
| ACTIVE INGREDIENTS | BLEOMYCIN |
| BRAND NAME | BLEOCIP |
| PACKING | SINGLE USE VIAL |
| STRENGTH | 15 UNIT/10ML |
| MFG BY | CIPLA LTD |
CLINICAL APPLICATIONS :
Bleocip is a glycopeptide antibiotic produced by the bacterium streptomyces verticillus. bleocip refers to a family of structurally related compounds. the mechanism of action involves breaking DNA.
STORAGE : Cold storage (2-8°C).
 |
SHUBHAM PHARMACEUTICAL
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Ltd. |
